PHILADELPHIA, PA / ACCESSWIRE / July 18, 2017 / Olfactory Biosciences Corp. (OTC PINK: OLFC) is pleased to announce a New Spin-off Company Dedicated to Launching NOXO Sensory Spectrum Disorders Gel™ and NOXO Binge Control™
New NOXO Sensory Spectrum Disorders Gel™ contains therapeutic natural ingredients, which are delivered to the brain via the olfactory receptors after topical application under the nose. Once NOXO Sensory Spectrum Disorders Gel™ is inhaled, the NOXO molecules transport their “messages” directly to the brain’s emotional center–the limbic system, and there is an improvement in sensory messaging processing.
Sensory Meltdowns are Neurological. A child with sensory processing disorder or autism may find that meltdowns are eliminated with NOXO Sensory Spectrum Disorders Gel™, or it has helped improve behavior and social engagement.
NOXO Binge Control™
For many people, compulsive overeating is part of a cycle that starts with a restrictive diet. Many call it the “eat, repent, repeat” cycle. You might begin a diet because you feel bad about your weight or size but find that it’s too hard to stick to — especially if you use food as a coping tool. Eventually, you hit a breaking point and binge on “forbidden” foods, and then the guilt and shame set in, and the restrictions begin again. This cycle can be avoided with NOXO Binge Control™
Corporate: OLFC is creating a spin-off company to market the above products. This spinoff will provide shareholders ownership in two leading and focused companies while providing the opportunity to value our proprietary products. “We believe this spinoff will create significant shareholder value,” said Rick Stevenson, President, and CEO.
Ingredients: A special proprietary formulation of Phytonutrients and Phytochemicals taken from plants, flowers, roots, and seeds. All ingredients are in a soy base which is FDA approved for cosmetic use. The specific chemical identities of the ingredients in this mixture are considered by us to be trade secrets and are withheld in accordance with the provisions of the 1910.1200 of the Code of Federal Regulations.
For Information about the company, go to http://olfcinvestor.com/.
FORWARD-LOOKING STATEMENTS “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995:
Statements by the Company, statements regarding the NOXO product line, optimism related to the business, expanding ales and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates, and projections about the Company’s business. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many factors including continued market acceptance of the Company’s products or the need to raise additional capital. In addition, actual results could vary materially based on changes or slower growth in the indoor garden market; the potential inability to realize expected benefits and synergies; domestic and international business and economic conditions; changes in customer demand or ordering patterns; changes in the competitive environment including pricing pressures or technological changes; technological advances; shortages of manufacturing capacity; future production variables impacting excess inventory and other risk factors listed from time to time in the Company’s Securities and Exchange Commission (SEC) filings under “risk factors” and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.
SOURCE: Olfactory Biosciences Corp.